SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-051089
Filing Date
2024-12-20
Accepted
2024-12-20 17:00:31
Documents
14
Period of Report
2024-12-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54198
  Complete submission text file 0001493152-24-051089.txt   284673

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20241217.xsd EX-101.SCH 3883
3 XBRL DEFINITION FILE cdt-20241217_def.xml EX-101.DEF 30185
4 XBRL LABEL FILE cdt-20241217_lab.xml EX-101.LAB 37007
5 XBRL PRESENTATION FILE cdt-20241217_pre.xml EX-101.PRE 27208
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6154
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 241568750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)